Renova Therapeutics Stock

renovatherapeutics.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $47.33MM

Renova Therapeutics is the developer of a portfolio of definitive gene and peptide therapies to restore health to people suffering from cardiovascular and metabolic diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Renova Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Renova Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Renova Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Richard McCloskey MD
Executive Vice President, Clinical Development
Roy Cosan
Board Member & President
Craig Andrews JD
Co-Founder, Board Member and Secretary
Catherine Bovenizer
Chief Financial Officer
Jack Reich Ph.D
Co-Founder, Chief Executive Officer & Board Member
Jennifer Spinella
Executive Vice President of Regulatory Affairs and Quality Assurance

Board Members

Andy Noorda
Kirk Hammond MD
Craig Andrews JD
Roy Cosan
Daniel Bradbury
Michael Torres
Jack Reich Ph.D

Renova Therapeutics’ stock FAQs


Can you buy Renova Therapeutics’ stock?

Renova Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Renova Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Renova Therapeutics’ stock?

Yes, you can sell stock of a private company like Renova Therapeutics. Forge can help you sell your Renova Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Renova Therapeutics’ stock price?

Renova Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Renova Therapeutics’ private market stock price with Forge Data.

What is Renova Therapeutics’ stock ticker symbol?

Renova Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Renova Therapeutics announces Delaware reincorporation

/PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic...

CEO and Co-Founder of Renova Therapeutics receives Entrepreneur of the Year award from Washington & Jefferson College

Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.